You are here

Clinical Trials: Vascular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, September 13, 2023 - 12:00
Conditions:   Wound Healing;   Diabetic Foot;   Chronic Foot Ulcer;   Foot Ulcer
Intervention:   Device: Endoform™ Antibacterial, Endoform™ Natural, Symphony™
Sponsors:   Aroa Biosurgery Limited;   Professional Education and Research Institute
Recruiting
Posted: Wednesday, September 13, 2023 - 12:00
Conditions:   Diabetic Foot;   Diabetic Foot Ulcer;   Foot Ulcer;   Chronic Foot Ulcer
Interventions:   Device: Symphony™ plus Off-loading;   Device: Wound Dressing comprising of calcium alginate Fibracol
Sponsors:   Aroa Biosurgery Limited;   Professional Education and Research Institute
Recruiting
Posted: Monday, September 11, 2023 - 12:00
Conditions:   Venous Ulcer;   Sickle Cell Ulcer;   Diabetic Ulcer;   Post-partum Women
Interventions:   Other: Saliva sampling;   Other: Blood sampling;   Other: Interviews;   Other: Clinical examination
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Tuesday, August 22, 2023 - 12:00
Conditions:   Diabetic Foot;   Diabetic Foot Ulcer;   Diabetic Foot Ulcer Neuropathic
Interventions:   Biological: hOMSC200;   Other: Placebo
Sponsor:   Cytora Ltd.
Recruiting
Posted: Tuesday, August 15, 2023 - 12:00
Condition:   Acute Ischemic Stroke
Interventions:   Drug: iEPCs;   Combination Product: Clinical standard treatment (CST)
Sponsor:   Allife Medical Science and Technology Co., Ltd.
Not yet recruiting
Posted: Thursday, July 27, 2023 - 12:00
Condition:   Venous Ulcer
Interventions:   Biological: Bioengineered Artificial Mesenchimal Sheet (BAMS);   Procedure: Standard treatment (Control)
Sponsor:   Andalusian Network for Design and Translation of Advanced Therapies
Recruiting
Posted: Friday, July 21, 2023 - 12:00
Condition:   Acute Cerebral Ischemia
Interventions:   Drug: Sovateltide;   Other: Normal Saline
Sponsor:   Pharmazz, Inc.
Recruiting
Posted: Tuesday, May 23, 2023 - 12:00
Conditions:   Atherosclerosis;   Cardiovascular Diseases;   Diabetes Mellitus, Type 2;   Obesity
Intervention:   Drug: Semaglutide Pen Injector
Sponsors:   Canadian Medical and Surgical Knowledge Translation Research Group;   Unity Health Toronto;   Western University, Canada
Recruiting
Posted: Thursday, May 11, 2023 - 12:00
Conditions:   Critical Limb Ischemia;   Buerger's Disease
Intervention:   Biological: Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells
Sponsors:   Cell Biopeutics Resources Sdn Bhd;   Stempeutics Research Pvt Ltd;   National University of Malaysia
Not yet recruiting
Posted: Thursday, May 11, 2023 - 12:00
Conditions:   Critical Limb Ischemia;   Peripheral Arterial Disease
Intervention:   Biological: Stempeucel®
Sponsors:   Cell Biopeutics Resources Sdn Bhd;   Stempeutics Research Pvt Ltd;   National University of Malaysia
Not yet recruiting

Pages